Rational thresholding of circulating tumor DNA concentration for improved surveillance of metastatic breast cancer
-
Published:2024-02
Issue:2
Volume:9
Page:102235
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Martens G.A.ORCID,
Demol J.,
Dedeurwaerdere F.ORCID,
Breyne J.,
De Smet K.ORCID,
De Jaeger P.ORCID,
De Smet D.
Subject
Cancer Research,Oncology
Reference27 articles.
1. ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer;Gennari;Ann Oncol,2021
2. International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer;Lin;Breast,2013
3. Serum tumor markers in breast cancer: are they of clinical value?;Duffy;Clin Chem,2006
4. Tumor markers in breast cancer-European Group on Tumor Markers recommendations;Molina;Tumour Biol,2005
5. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers;Sturgeon;Clin Chem,2008